Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 39, Issue 6, Pages 1516-1526Publisher
WILEY
DOI: 10.1002/eji.200839176
Keywords
EAE/MS; Neuroimmunology; T cells; Transgenic/knockout mice
Categories
Funding
- National Multiple Sclerosis Society [RG 3437-B-9]
- National Institutes of Health [T32 AI07051]
- EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD034373] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER
Ask authors/readers for more resources
We have previously shown that gamma delta T cells traffic to the CNS during EAE with concurrently increased expression of beta(2)-integrins and production of IFN-gamma and TNF-alpha. To extend these studies, we transferred bioluminescent gamma delta T cells to WT mice and followed their movement through the acute stages of disease. We found that gamma delta T cells rapidly migrated to the site of myelin oligodendrocyte glycoprotein peptide injection and underwent massive expansion. Within 6 days after EAE induction, bioluminescent gamma delta T cells were found in the spinal cord and brain, peaking in number between days 10 and 12 and then rapidly declining by day 15. Reconstitution of gamma delta T cell(-/-) mice with gamma delta T cells derived from beta(2)-integrin-deficient mice (CD11a, -b or -c) demonstrated that gamma delta T-cell trafficking to the CNS during EAE is independent of this family of adhesion molecules. We also examined the role Of 78 T-cell-produced IFN-gamma and TNF-alpha in EAE and found that production of both cytokines by gamma delta T cells was required for full development of EAE. These results indicate that gamma delta T cells are critical for the development of EAE and suggest a therapeutic target in demyelinating disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available